A novel cardiometabolic therapeutic prospect Cardiometabolic diseases as diabetes mellitus, heart disease, overweight, obesity, hypertension, hyperlipidemia and its multiple macro and microvascular complications (ischemic cardiomyopathy, stroke, chronic kidney disease, retinopathy, peripheral neuropathy, etc.) are conditions closely related to each other and constitute at present time the leading cause of morbility, disability and death in the world [28]
Heart failure with preserved ejection fraction (HFpEF) (e.g, STEP-HFpEF and SUMMIT), 4
In addition, it is of utmost importance to make sure all the lifestyle factors are dialed in first
Nadolsky sees room for smaller companies to differentiate, even with the bar set extraordinarily high
While GLP-1 medications have certainly exploded in use and cost, theyre not the only game in town
This combination can indicate an obstruction